Envoy Medical prices $2.5M registered direct offering at $1.31/share, plus warrants for up to $7.5M

Envoy Medical, Inc.

Gross proceeds ~$2.5M from sale of 1,908,402 shares at $1.31/share; close expected Sept 23, 2025.
Concurrent private placement of warrants for 5,725,206 shares at $1.31, exercisable after stockholder approval.
Full warrant exercise could yield additional ~$7.5M in proceeds; warrants expire 24 months after stockholder approval.
Net proceeds for working capital and general corporate purposes.
H.C. Wainwright acts as placement agent; receives 7.5% cash fee and additional warrants.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

Envoy Medical, Inc. issued 5,725,206 shares of Common Stock of warrant to the Purchasers for Issued in connection with the registered direct offering of common stock.

Security: warrant
Shares: 5,725,206 shares of Common Stock
Purchaser: the Purchasers
Consideration: Issued in connection with the registered direct offering of common stock

Exact text from the filing

the Company agreed to issue to the Purchasers warrants (the “Private Warrants”) to purchase up to an aggregate of 5,725,206 shares of Common Stock (the “Warrant Shares”).

View on SEC.gov

Browse all equity issuances →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-090373

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.